Spalt-like Transcription Factor 4 Expression in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma: An Immunohistochemical Appraisal

Overview

Journal J Carcinog

Publisher Biomed Central

Date 2021 Mar 8

PMID 33679242

Citations 4

Authors

Spoorti Kulkarni

Monica Solomon

Chetana Chandrashekar

Nisha Shetty

Sunitha Carnelio

Affiliations

Soon will be listed here.

Abstract

Background: Spalt-like transcription factor 4 (SALL4) is a stem cell marker that plays a critical role in maintaining the pluripotency and self-renewal of embryonic and hematopoietic stem cells. Only a few studies have been done to apprehend the expression of SALL4 in the potentially malignant oral lesion (leukoplakia with dysplasia) and oral squamous cell carcinoma (OSCC).

Aim: The aim of this study is to evaluate the expression of SALL4 in leukoplakia with dysplasia and OSCC and to correlate the expression of the marker (SALL4) with the various clinicopathological parameters and patient outcome.

Materials And Methods: Immunohistochemistry for SALL4 protein was performed on 140 cases: those histopathologically confirmed cases of leukoplakia with dysplasia ( = 30) and OSCC ( = 110). Ten cases of nonepithelial neoplasm (fibroepithelial hyperplasia and excised tissue surrounding impacted third molars) were taken as control. Statistical analyses were applied to evaluate correlations between SALL4 overexpression and clinicopathological features of leukoplakia and OSCC. Survival rates were analyzed using Kaplan-Meier method.

Results: SALL4 positivity was observed to be higher ( = 0.001) in the tumor cells of OSCC with Immuno Reactive Score (IRS) ranging from 0 to 9. Poorly differentiated squamous cell carcinoma (SCC) had paramount higher expression with a median IRS of 6. Similar IRS and above (IRS, 6-9) was observed in Stage I (five cases), which recurred and well-differentiated cases with metastasis (four cases) while in leukoplakia with dysplasia the SALL4 expression was weak with a range of 2-4.

Conclusions: SALL4 being one of the cancer stem cell molecules plays an important role in the progression of oral cancer, which was evident in this study. This could also account for aggressive clinical behavior. Follow-up of these patients would relate this molecule could be responsible for cancer relapse. Patients diagnosed to have oral epithelial dysplasia had a low expression of SALL4, are under follow-up, although seven cases did transform to SCC. Thus, we conclude, SALL4 may be of prognostic relevance, but in oral epithelial dysplasia, it requires further investigations.

Citing Articles

Expression of CD44 and SALL4 in Leukoplakia and Oral Squamous Cell Carcinoma.

Sahoo P, Kumar H, Panda A, Dash K, Bhuyian L, Raghuvanshi M J Pharm Bioallied Sci. 2024; 16(Suppl 2):S1761-S1763.

PMID: 38882798 PMC: 11174256. DOI: 10.4103/jpbs.jpbs_1178_23.

Expression of stem cell markers SALL4, LIN28A, and KLF4 in ameloblastoma.

de Albuquerque Dias R, Balbinot K, da Silva Kataoka M, de Melo Alves Junior S, de Jesus Viana Pinheiro J Diagn Pathol. 2023; 18(1):92.

PMID: 37559082 PMC: 10413759. DOI: 10.1186/s13000-023-01379-9.

The new advance of SALL4 in cancer: Function, regulation, and implication.

Abouelnazar F, Zhang X, Wang M, Zhang J, Yu D, Zang X J Clin Lab Anal. 2023; 37(9-10):e24927.

PMID: 37337914 PMC: 10388233. DOI: 10.1002/jcla.24927.

Potential application of human SALL4 on oral squamous cell carcinoma.

Matos L, da Silva J Ann Transl Med. 2022; 10(17):919.

PMID: 36172107 PMC: 9511190. DOI: 10.21037/atm-22-3982.

References

Zhang X, Yuan X, Zhu W, Qian H, Xu W . SALL4: an emerging cancer biomarker and target. Cancer Lett. 2014; 357(1):55-62. DOI: 10.1016/j.canlet.2014.11.037. View

van der Waal I, Schepman K, van der Meij E . A modified classification and staging system for oral leukoplakia. Oral Oncol. 2000; 36(3):264-6. DOI: 10.1016/s1368-8375(99)00092-5. View

Oikawa T, Kamiya A, Zeniya M, Chikada H, Hyuck A, Yamazaki Y . Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers. Hepatology. 2012; 57(4):1469-83. PMC: 6669886. DOI: 10.1002/hep.26159. View

Yu H, Featherston T, Tan S, Chibnall A, Brasch H, Davis P . Characterization of Cancer Stem Cells in Moderately Differentiated Buccal Mucosal Squamous Cell Carcinoma. Front Surg. 2016; 3:46. PMC: 4970507. DOI: 10.3389/fsurg.2016.00046. View

Whiteside S, Goodbourn S . Signal transduction and nuclear targeting: regulation of transcription factor activity by subcellular localisation. J Cell Sci. 1993; 104 ( Pt 4):949-55. DOI: 10.1242/jcs.104.4.949. View

Li A, Jiao Y, Yong K, Wang F, Gao C, Yan B . SALL4 is a new target in endometrial cancer. Oncogene. 2013; 34(1):63-72. PMC: 4059794. DOI: 10.1038/onc.2013.529. View

Klein M, Vignaud J, Hennequin V, Toussaint B, Bresler L, Plenat F . Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma. J Clin Endocrinol Metab. 2001; 86(2):656-8. DOI: 10.1210/jcem.86.2.7226. View

Miller A, Ralser M, Kloet S, Loos R, Nishinakamura R, Bertone P . Sall4 controls differentiation of pluripotent cells independently of the Nucleosome Remodelling and Deacetylation (NuRD) complex. Development. 2016; 143(17):3074-84. PMC: 5047675. DOI: 10.1242/dev.139113. View

Wu M, Yang F, Ren Z, Jiang Y, Ma Y, Chen Y . Identification of the nuclear localization signal of SALL4B, a stem cell transcription factor. Cell Cycle. 2014; 13(9):1456-62. PMC: 4050143. DOI: 10.4161/cc.28418. View

10.

Lim C, Tam W, Zhang J, Ang H, Jia H, Lipovich L . Sall4 regulates distinct transcription circuitries in different blastocyst-derived stem cell lineages. Cell Stem Cell. 2008; 3(5):543-54. DOI: 10.1016/j.stem.2008.08.004. View

11.

Chen M, Li L, Zheng P . SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β-catenin pathway via CTNNB1. Cancer Sci. 2019; 110(9):2794-2805. PMC: 6726833. DOI: 10.1111/cas.14140. View

12.

Perez-Sayans M, Somoza-Martin J, Barros-Angueira F, Reboiras-Lopez M, Gandara Rey J, Garcia-Garcia A . Genetic and molecular alterations associated with oral squamous cell cancer (Review). Oncol Rep. 2009; 22(6):1277-82. DOI: 10.3892/or_00000565. View

13.

Yang J, Gao C, Chai L, Ma Y . A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One. 2010; 5(5):e10766. PMC: 2874005. DOI: 10.1371/journal.pone.0010766. View

14.

Wilson C, Crombie C, van der Weyden L, Poulogiannis G, Rust A, Pardo M . Nuclear receptor binding protein 1 regulates intestinal progenitor cell homeostasis and tumour formation. EMBO J. 2012; 31(11):2486-97. PMC: 3365428. DOI: 10.1038/emboj.2012.91. View

15.

Zhang L, Xu Z, Xu X, Zhang B, Wu H, Wang M . SALL4, a novel marker for human gastric carcinogenesis and metastasis. Oncogene. 2013; 33(48):5491-500. DOI: 10.1038/onc.2013.495. View

16.

Itou J, Li W, Ito S, Tanaka S, Matsumoto Y, Sato F . Sal-like 4 protein levels in breast cancer cells are post-translationally down-regulated by tripartite motif-containing 21. J Biol Chem. 2018; 293(17):6556-6564. PMC: 5925811. DOI: 10.1074/jbc.RA117.000245. View

17.

Lin Y, Liu A, Fan C, Zheng H, Li Y, Zhang C . MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1. Sci Rep. 2015; 5:9995. PMC: 4412117. DOI: 10.1038/srep09995. View

18.

Yang F, Yao Y, Jiang Y, Lu L, Ma Y, Dai W . Sumoylation is important for stability, subcellular localization, and transcriptional activity of SALL4, an essential stem cell transcription factor. J Biol Chem. 2012; 287(46):38600-8. PMC: 3493905. DOI: 10.1074/jbc.M112.391441. View

19.

Shin K, Kim R . An Updated Review of Oral Cancer Stem Cells and Their Stemness Regulation. Crit Rev Oncog. 2018; 23(3-4):189-200. PMC: 6436811. DOI: 10.1615/CritRevOncog.2018027501. View

20.

Yue X, Xiao L, Yang Y, Liu W, Zhang K, Shi G . High cytoplasmic expression of SALL4 predicts a malignant phenotype and poor prognosis of breast invasive ductal carcinoma. Neoplasma. 2015; 62(6):980-8. DOI: 10.4149/neo_2015_119. View